TORONTO, ON / ACCESSWIRE / November 19, 2020 / ITOCO INC. (OTC PINK:ITMC) has released a list of companies and organizations addressing Virus testing through time-of-presentation (TOP) solutions.
TOP solutions provide updated status of vaccination and/or testing at point of contact.
Time of Presentation verification solutions refer to systems which uses verification to prove that a person presenting themselves to an event, physical location or service has completed a certain action, such as vaccination and/or virus test taking within a certain time period, and its result. These solutions can form a critical part of industries such as live events, trade shows, cruise lines, airlines and hospitality in opening more quickly and safely in 2021.
The list of companies and organizations available on the ITOCO blog post at www.itoco.net include Ticketmaster (LYV), Cathay Pacific (0293), United Airlines (UAL), Royal Caribbean (RCL), Carnival (CCL) and ITOCO (OTC PINK:ITMC).
This latest technology release is a critical next step in commercializing the patent-pending ITOCO Immutable Virus Test Result Verification System and makes it available for testing and integration with various virus test technologies as well as commercial customers and partners.
As mentioned previously, ITOCO's mobile app for Immutable Virus Test Result Verification will be released via Apple Store and Google Play Store shortly.
Features and benefits for potential customers and users include:
- A biometric reader and blockchain wallet to create an immutable digital identity on the blockchain while protecting privacy.
- Integration with the administrative application so that users can be added securely to the blockchain and connected to virus test machines which write immutable test results to the blockchain
- Direct connection with the blockchain to immutably verify that the person presenting the application is who they say they are and therefore the virus test results are in fact theirs.
"ITOCO remains committed to researching and sharing relevant industry information on our biotech blog. We recognize that it takes many different companies and organizations working on different approaches to the same problem to address the market need. We are committed through our own patent-pending system both on our own and through collaboration with other key providers to be part of the list of potential solutions." said Michael Paul, CEO of ITOCO.
About ITOCO Inc.
ITOCO's mission is to be a global leader in developing, distributing, and producing Bio Tech related technologies and methodologies in a compliant environmentally friendly manner. ITOCO Inc. trades on the OTC Markets, symbol: ITMC. ITOCO is a 13-year-old publicly quoted specialty Bio Tech development, production and distribution company based in Toronto Canada and Nevada USA. ITOCO seeks to partner with outstanding individuals and companies within this field to joint venture, research, and co-develop Bio Tech related products and technologies to the market.
Forward-Looking Statements
This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, potential, intends, plans, hopes, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.
CONTACT
ITOCO INC.
Michael Paul
[email protected]
+1 (905) 829-5000
www.itoco.net
SOURCE: ITOCO Inc.